Clinical practice guideline for quality control of hemodiafiltration

This guideline was co-authored by a writing committee of experts in hemodiafiltration. Based on the current evidence-based resources, the guideline drew on and referred to the current relevant clinical practice guidelines and expert recommendations at home and abroad, as well as the Standard Operating Procedures for Blood Purification (2021 Edition), focusing on clinical and medical quality control issues such as the indications for hemodiafiltration, the selection of treatment modes, the selection of replacement fluid and the adjustment of components, vascular access, anticoagulation therapy, prescription setting, and prevention and treatment of related complications. The guideline aimed to guide the clinical practice and clinical research of hemodiafiltration in China, and improve the standardization, normalization and homogeneity of medical quality of hemodiafiltration.

《血液透析滤过质量控制临床实践指南》由血液净化专家组成的编写委员会共同编写，基于目前循证医学证据，同时借鉴和参考了目前国内外相关临床实践指南与专家建议以及《血液净化标准操作规程（2021版）》，重点针对血液透析滤过的适应证、治疗模式选择、置换液的选择与成分调整、血管通路、抗凝治疗、处方设置以及相关并发症防治等临床及其医疗质量控制问题，提出推荐意见和相关医疗质控指标。目的在于指导我国血液透析滤过的临床实践和临床研究，提高血液透析滤过医疗质量的标准化、规范化和同质化。.